COST-EFFECTIVENESS ANALYSIS OF ERLOTINIB VERSUS DOCETAXEL AS A SECOND- OR THIRD-LINE TREATMENT OF NON-SMALL CELL LUNG CANCER IN KOREA
  • Kim, Y. G.
  • Lee, E. K.
Citations

WEB OF SCIENCE

1
Citations

SCOPUS

0
제목
COST-EFFECTIVENESS ANALYSIS OF ERLOTINIB VERSUS DOCETAXEL AS A SECOND- OR THIRD-LINE TREATMENT OF NON-SMALL CELL LUNG CANCER IN KOREA
저자
Kim, Y. G.Lee, E. K.
DOI
10.1016/S1098-3015(11)73117-5
발행일
2010-11
유형
Meeting Abstract
저널명
Value in Health
13
7
페이지
A514 ~ A514